Updated Overall Survival Analysis in Oceans, a Randomized Phase 3 Trial of Gemcitabine (G) + Carboplatin (C) and Bevacizumab (BV) or Placebo (PL) Followed by BV or PL in Platinum-Sensitive Recurrent Epithelial Ovarian (ROC), Primary Peritoneal (PPC), or Fallopian Tube Cancer (FTC)

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 23; p. ix319
Main Authors Aghajanian, C., Nycum, L.R., Goff, B., Nguyen, H., Husain, A., Blank, S.V.
Format Journal Article
LanguageEnglish
Published 01.09.2012
Online AccessGet full text

Cover

More Information
ISSN:0923-7534
DOI:10.1016/S0923-7534(20)33532-8